EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function—a prespecified substudy from REDUCE-AMI

Katarina Mars iD, Sophia Humphries iD, Philip Leissner, Martin Jonsson iD, Patric Karlström, Jörg Lauermann, Joakim Alfredsson iD, Thomas Kellerth, Annica Ravn-Fischer iD, David Erlinge, Bertil Lindahl iD, Troels Yndigegn iD und 4 weitere

European Heart Journal - Cardiovascular Pharmacotherapy · 2025

DOI: 10.1093/ehjcvp/pvae062 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Heart Journal - Cardiovascular Pharmacotherapy, 2025. Verfasst von Katarina Mars und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science and Education, Division of Cardiology, Karolinska Institutet, Södersjukhuset, Stockholm, Sjukhusbacken 10, 188 83, Swe…. Hauptthemen laut MEDLINE: Quality of Life, Adrenergic beta-Antagonists, Ventricular Function, Left, Myocardial Infarction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Heart Lung Foundation, Swedish Heart and Lung Association, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In the Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial Infarction (REDUCE-AMI) study, long-term beta-blocker use in patients after acute myocardial infarction (AMI) with preserved left ventricular ejection fraction demonstrated no effect on death or cardiovascular outcomes. The aim of this prespecified substudy was to investigate effects of beta-blockers on self-reported quality of life and well-being. Methods and results From this parallel-group, open-label, registry-based randomized clinical trial, EQ-5D, and World Health Organization well-being index-5 (WHO-5) questionnaires were obtained at 6–10 weeks and 11–13 months after AMI in 4080 and 806 patients, respectively. We report results from intention-to-treat and on-treatment analyses for the overall population and relevant subgroups using Wilcoxon rank sum test and adjusted ordinal regression analyses. Of the 4080 individuals reporting EQ-5D (median age 64 years, 22% female), 2023 were randomized to beta-blockers. The main outcome, median EQ-5D index score, was 0.94 [interquartile range (IQR) 0.88, 0.97] in the beta-blocker group, and 0.94 (IQR 0.88, 0.97) in the no-beta-blocker group 6–10 weeks after AMI, OR 1.00 [95% CI 0.89–1.13; P > 0.9]. After 11–13 months, results remained unchanged. Findings were robust in on-treatment analyses and across relevant subgroups. Secondary outcomes, EQ-VAS and WHO-5 index score, confirmed these results.

Conclusion

Among patients after AMI with preserved left ventricular ejection fraction, self-reported quality of life and well-being was not significantly different in individuals randomized to routine long-term beta-blocker therapy as compared to individuals with no beta-blocker use. These results appear consistent regardless of adherence to randomized treatment and across subgroups which emphasizes the need for a careful individual risk-benefit evaluation prior to initiation of beta-blocker treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeAdrenergic beta-AntagonistsVentricular Function, LeftMyocardial InfarctionHumansFemaleMaleMiddle AgedAgedTreatment OutcomeTime FactorsStroke VolumeRegistries

Stichwörter der Autor:innen

AMI: Acute myocardial infarctionEQ-5D: EuroQoL 5-dimensionEQ-VAS: EuroQoL visual analogue scaleLVEF: Left ventricular ejection fractionQoL: Quality of lifeSWEDEHEART: Swedish Web System for Enhancement and Development of Evidence-base…WHO-5: World Health Organization-5

Substanzen

Adrenergic beta-Antagonists

Autor:innen und Institutionen

  • Department of Clinical Science and Education, Division of Cardiology, Karolinska Institutet, Södersjukhuset, Stockholm, Sjukhusbacken 10, 188 83, Sweden.
  • Department of Women's and Children's Health, Uppsala University, Uppsala 751 85, Sweden.
  • Department of Internal Medicine, Ryhov County Hospital, Jönköping 551 85 Sweden.
  • Department of Cardiology and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping 581 83, Sweden.
  • Division of Cardiology and Emergency medicine, Centralsjukhuset Karlstad, Karlstad 651 82, Sweden.
  • Department of Cardiology, Sahlgrenska University Hospital, Gothenburg 405 30, Sweden.

ORCID-Profile: Katarina Mars, Sophia Humphries, Martin Jonsson, Joakim Alfredsson, Annica Ravn-Fischer, Bertil Lindahl, Troels Yndigegn, Claes Held, Robin Hofmann

Förderung

  • Swedish Heart Lung Foundation
  • Swedish Heart and Lung Association
  • Swedish Research Council

Zitieren

APA

Mars, K., Humphries, S., Leissner, P., Jonsson, M., Karlström, P., Lauermann, J., Alfredsson, J., Kellerth, T., Ravn-Fischer, A., Erlinge, D., Lindahl, B., Yndigegn, T., Jernberg, T., Held, C., Olsson, E. M. G., & Hofmann, R. (2025). Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function—a prespecified substudy from REDUCE-AMI. European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvae062

Vancouver

Mars K, Humphries S, Leissner P, Jonsson M, Karlström P, Lauermann J, et al. Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function—a prespecified substudy from REDUCE-AMI. European Heart Journal - Cardiovascular Pharmacotherapy. 2025. doi:10.1093/ehjcvp/pvae062

BibTeX
@article{Mars2025,
  author = {Mars, Katarina and Humphries, Sophia and Leissner, Philip and Jonsson, Martin and Karlström, Patric and Lauermann, Jörg and Alfredsson, Joakim and Kellerth, Thomas and Ravn-Fischer, Annica and Erlinge, David and Lindahl, Bertil and Yndigegn, Troels and Jernberg, Tomas and Held, Claes and Olsson, Erik M G and Hofmann, Robin},
  title = {Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function—a prespecified substudy from REDUCE-AMI},
  journal = {European Heart Journal - Cardiovascular Pharmacotherapy},
  year = {2025},
  doi = {10.1093/ehjcvp/pvae062}
}
Kostenlos starten →